226 related articles for article (PubMed ID: 22795452)
1. Acne relapse rate and predictors of relapse following treatment with oral isotretinoin.
Morales-Cardona CA; Sánchez-Vanegas G
Actas Dermosifiliogr; 2013 Jan; 104(1):61-6. PubMed ID: 22795452
[TBL] [Abstract][Full Text] [Related]
2. High-dose isotretinoin treatment and the rate of retrial, relapse, and adverse effects in patients with acne vulgaris.
Blasiak RC; Stamey CR; Burkhart CN; Lugo-Somolinos A; Morrell DS
JAMA Dermatol; 2013 Dec; 149(12):1392-8. PubMed ID: 24173086
[TBL] [Abstract][Full Text] [Related]
3. Isotretinoin therapy and the incidence of acne relapse: a nested case-control study.
Azoulay L; Oraichi D; Bérard A
Br J Dermatol; 2007 Dec; 157(6):1240-8. PubMed ID: 17970803
[TBL] [Abstract][Full Text] [Related]
4. Oral isotretinoin for acne, adjusting treatment according to patient's response.
Ghaffarpour G; Mazloomi S; Soltani-Arabshahi R; Seyed KS
J Drugs Dermatol; 2006 Oct; 5(9):878-82. PubMed ID: 17039654
[TBL] [Abstract][Full Text] [Related]
5. High-dose isotretinoin in acne vulgaris: improved treatment outcomes and quality of life.
Cyrulnik AA; Viola KV; Gewirtzman AJ; Cohen SR
Int J Dermatol; 2012 Sep; 51(9):1123-30. PubMed ID: 22909370
[TBL] [Abstract][Full Text] [Related]
6. Maintenance therapy for acne vulgaris: efficacy of a 12-month treatment with adapalene-benzoyl peroxide after oral isotretinoin and a review of the literature.
Bettoli V; Borghi A; Zauli S; Toni G; Ricci M; Giari S; Virgili A
Dermatology; 2013; 227(2):97-102. PubMed ID: 24029411
[TBL] [Abstract][Full Text] [Related]
7. Assessment of the efficacy and safety of a combination of 2 topical retinoids (RetinSphere) in maintaining post-treatment response of acne to oral isotretinoin.
Truchuelo MT; Jiménez N; Mavura D; Jaén P
Actas Dermosifiliogr; 2015 Mar; 106(2):126-32. PubMed ID: 25306870
[TBL] [Abstract][Full Text] [Related]
8. Prospective study of risk factors of relapse after treatment of acne with oral isotretinoin.
Quéreux G; Volteau C; N'Guyen JM; Dréno B
Dermatology; 2006; 212(2):168-76. PubMed ID: 16484824
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the efficacies of intermittent and continuous low-dose isotretinoin regimens in the treatment of moderate acne vulgaris.
Boyraz N; Mustak PK
Int J Dermatol; 2013 Oct; 52(10):1265-7. PubMed ID: 23675954
[TBL] [Abstract][Full Text] [Related]
10. Low-dose schema of isotretinoin in acne vulgaris.
Mandekou-Lefaki I; Delli F; Teknetzis A; Euthimiadou R; Karakatsanis G
Int J Clin Pharmacol Res; 2003; 23(2-3):41-6. PubMed ID: 15018017
[TBL] [Abstract][Full Text] [Related]
11. An expert view on the treatment of acne with systemic antibiotics and/or oral isotretinoin in the light of the new European recommendations.
Dréno B; Bettoli V; Ochsendorf F; Perez-Lopez M; Mobacken H; Degreef H; Layton A
Eur J Dermatol; 2006; 16(5):565-71. PubMed ID: 17101480
[TBL] [Abstract][Full Text] [Related]
12. Making sense of the effects of the cumulative dose of isotretinoin in acne vulgaris.
Rademaker M
Int J Dermatol; 2016 May; 55(5):518-23. PubMed ID: 26471145
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of conventional, low-dose and intermittent oral isotretinoin in the treatment of acne: a randomized, controlled comparative study.
Lee JW; Yoo KH; Park KY; Han TY; Li K; Seo SJ; Hong CK
Br J Dermatol; 2011 Jun; 164(6):1369-75. PubMed ID: 21114478
[TBL] [Abstract][Full Text] [Related]
14. Relapse of acne following isotretinoin treatment: a retrospective study of 405 patients.
Liu A; Yang DJ; Gerhardstein PC; Hsu S
J Drugs Dermatol; 2008 Oct; 7(10):963-6. PubMed ID: 19112761
[TBL] [Abstract][Full Text] [Related]
15. Analysis of clinical efficacy, side effects, and laboratory changes among patients with acne vulgaris receiving single versus twice daily dose of oral isotretinoin.
Ahmad HM
Dermatol Ther; 2015; 28(3):151-7. PubMed ID: 25754162
[TBL] [Abstract][Full Text] [Related]
16. Comparison of combined azelaic acid cream plus oral minocycline with oral isotretinoin in severe acne.
Gollnick HP; Graupe K; Zaumseil RP
Eur J Dermatol; 2001; 11(6):538-44. PubMed ID: 11701404
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of fixed low-dose isotretinoin (20 mg, alternate days) with topical clindamycin gel in moderately severe acne vulgaris.
Sardana K; Garg VK; Sehgal VN; Mahajan S; Bhushan P
J Eur Acad Dermatol Venereol; 2009 May; 23(5):556-60. PubMed ID: 19143903
[TBL] [Abstract][Full Text] [Related]
18. Dermabrasion for acne scars during treatment with oral isotretinoin.
Bagatin E; dos Santos Guadanhim LR; Yarak S; Kamamoto CS; de Almeida FA
Dermatol Surg; 2010 Apr; 36(4):483-9. PubMed ID: 20180836
[TBL] [Abstract][Full Text] [Related]
19. Low-dose isotretinoin in the treatment of acne vulgaris.
Amichai B; Shemer A; Grunwald MH
J Am Acad Dermatol; 2006 Apr; 54(4):644-6. PubMed ID: 16546586
[TBL] [Abstract][Full Text] [Related]
20. The truth behind this undeniable efficacy--recurrence rates and relapse risk factors of acne treatment with oral isotretinoin.
Zouboulis CC
Dermatology; 2006; 212(2):99-100. PubMed ID: 16484812
[No Abstract] [Full Text] [Related]
[Next] [New Search]
